Chronic spontaneous urticaria is an idiopathic syndrome defined by recurring itch, hives, or angioedema (or a combination of ...

Dr Adam Friedman recounts how AAD 2025 highlighted advancements in chronic spontaneous urticaria management, with discussion on new therapies and the role of diet.

慢性荨麻疹（Chronic Urticaria, CU）是一种常见的皮肤病，表现为反复发作的风团和瘙痒，通常持续超过6周。这种疾病不仅影响成人，也在儿童人群中广泛存在。尽管一些研究表明慢性荨麻疹在不同年龄段表现出特定差异，但关于儿童，尤其是5岁以下幼儿，慢性荨麻疹的临床特征数据及治疗方案仍然非常有限。

In this randomized controlled trial, among patients with chronic spontaneous urticaria who continue to have symptoms while on ...

For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H1-antihistamines, ...

Patients with chronic spontaneous urticaria that was not controlled with H1 antihistamines experienced improvements in itch ...

The severity of a patient’s chronic spontaneous urticaria impacted several outcomes, including quality of life and treatment satisfaction, according to results published in Annals of Allergy, Asthma ...

Chronic spontaneous urticaria is an idiopathic syndrome defined by recurring itch, hives, or angioedema (or a combination of these symptoms) for more than 6 weeks. Remibrutinib, an oral ...

A new groundbreaking study revealed that Remibrutinib showed promising results in treating chronic spontaneous urticaria.A recent study published in the New England Journal of Medicine outlined the ...

Assessment of her symptoms showed her Urticaria Activity Score over 7 consecutive days (UAS 7) was 35 per week. In September of that year, she was taken off hydroxyzine due to the side effect of ...

Remibrutinib significantly reduces itch and hives in patients with chronic spontaneous urticaria in two identical randomized ...

Therapeutics announced positive data on measurements of disease control and quality of life from the Company’s Phase 2 ...